H-2 Antigens (H 2 Antigens)

11/01/1989 - "However, no correlation was found between the levels of expression of H-2 antigens and the in vivo clearance of tumor cells. "
01/01/1999 - "When metastatic nodes were cultured, typed for H-2 antigens, and compared with the H-2 expression of the inducing tumor cell, H-2 Kd and Dd class I expression was greater in most nodes analyzed. "
03/01/1991 - "The increase in tumor cell immunogenicity induced by UV light was not associated with the appearance of Class I H-2 antigens. "
11/01/1986 - "This contrasted with parallelism between the expression of H-2 antigens and inducibility of cytotoxic T lymphocytes (CTL) or lysability of tumor cell clones by CTL. "
11/01/1986 - "The results demonstrated that there was no correlation between TATA activity capable of inducing in vivo tumor resistance and the expression of H-2 antigens. "

10/01/1987 - "The interaction of H-2 antigens and plasma membrane-associated filaments was studied on dry-cleaved preparations of immunogold-labelled lymphoma cells. "
03/01/1983 - "Characterization of T-cell-soluble factors modulating the expression of Ia and H-2 antigens on BALB/c B lymphoma cell lines."
04/01/1975 - "In some instances, a complete reversion of both the virus-specific and H-2 antigens was observed after a single passage of cultured lymphoma cells in syngeneic hosts."
11/01/1961 - "II. Behavior of H-2 antigens D and K: cytotoxic tests on mouse lymphomas."
01/01/1980 - "Such lymphomas are available only in a small number of inbred strains of mice, thus setting limits to the study of H-2 antigens in the interaction between CTL and tumor target cells. "

08/01/1975 - "Another antiserum is then prepared in the same strain combination by immunization with tissue that does not contain Ia but does contain H-2 antigens (e.g., a sarcoma of the proper genotype). "
11/01/1961 - "I. Behavior of H-2 antigens D and K: quantitative absorption tests on mouse sarcomas."
09/01/1977 - "Serologically active preparations of soluble H-2 antigens were obtained by 3 M KCl extraction from the ascitic cells of leukemia L 1210 (H-2d) and sarcoma MX-11 (H-2b). "
05/01/1986 - "Serological and immunochemical analysis of H-2 antigens subsequently showed that DOH sarcoma cells did not express syngeneic H-2K and H-2D antigens. "
01/01/1988 - "Murine RCT(+) sarcoma cells were sorted using a fluorescence-activated cell sorter with regard to the expression of H-2 antigens and then an increased H-2-expressing subclone was established, and named RCT(+)H-2+. The experimental metastasis of RCT(+) cells was compared with that of RCT(+)H-2+ cells by counting pulmonary colonies on the 21st day after i.v. inoculation of tumor cells (5-10 x 10(4)/mouse). "

05/15/1987 - "The present study is aimed to investigate the expression of protooncogenes in the T-10 fibrosarcoma lines that exhibit distinct metastatic properties in correlation with the expressed H-2 antigens. "
05/01/1984 - "These tumor cells and 1053 cells (a fibrosarcoma of C3H/HeN MTV- mice) could, however, be induced to express I-A, I-E, and much higher levels of H-2 antigens in vitro by co-culturing them with spleen cells from LT-85 tumor-bearing C3H/HeN MTV- mice. "
06/30/1979 - "Alien H-2 antigens on a chemically induced fibrosarcoma: further evidence in crude membrane and soluble extracts of the tumor."
08/01/1989 - "We have used the 3-Methylcholanthrene induced T-10 fibrosarcoma tumour cell system (H-2b xH-2k)F1 to elucidate the possible correlation between metastatic potential, expression of individual H-2 antigens and susceptibility to NK cells. "
01/15/1978 - "In vitro and in vivo expression of original and foreign H-2 antigens and of the tumor-associated transplantation antigen of a murine fibrosarcoma."

01/01/1993 - "Expression of ganglioside GM3 and H-2 antigens in clones with different metastatic and growth potentials isolated from Lewis lung carcinoma (3LL) cell line."
01/01/1986 - "The results of studies on the H-2 antigens expression on L1210 and P388 mouse lymphoma cells and their drug-resistant sublines as well as on Lewis lung carcinoma (LL2) cells and their wheat germ agglutinin-resistant variants (LL(2)5 and LL(2)8) are presented. "